A new briefing by HEAL (in English and in Turkish), as part of the EU funded CISIP project, underlines the many health benefits that could be gained if Turkish decision-makers implemented stronger Green Deal action. Turkey’s Green Deal Action Plan, launched in 2021, sets 32 objectives and 81 actions, including on a Green and Circular Economy, secure energy supply and sustainable agriculture. However, contrary to the EU Green Deal which was adopted in 2019, the Turkish plan doesn’t set any tangible targets or deadlines.
The report provides a review of the scientific evidence that certain chemicals may be implicated in breast cancer, and focuses on the role of hormone disrupting chemicals. Particular reference is made to early life and multiple chemical exposures. Written by Professor Andreas Kortenkamp, Head of the Centre for Toxicology, School of Pharmacy, University of London, UK, the report has been peer reviewed by Professor Jan Ake Gustafsson (whose team discovered the oestrogen receptor-beta), Dr Julia Brody from the Silent Spring Institute, USA, and Prof Alastair M Thompson, Professor of Surgical Oncology at the University of Dundee.
The fully referenced report identifies important areas for further discussion not only within the breast cancer and wider medical community but also within that of chemicals regulation.